The Journal of Urology
Volume 177, Issue 6 , Pages 2146-2150, June 2007

Phase II Study of Low Dose and High Dose Conjugated Estrogen for Androgen Independent Prostate Cancer

Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School and the Beth Israel Deaconess Medical Center, Boston, Massachusetts

Received 4 October 2006

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Supported by the Dunkin Donuts Rising Stars Research Fund.

PII: S0022-5347(07)00257-1

doi:10.1016/j.juro.2007.01.119

The Journal of Urology
Volume 177, Issue 6 , Pages 2146-2150, June 2007

Article Tools

* Image Usage & Resolution